Schedule & Sessions


8:00 – 8:30 am
8:30 – 8:40 am
8:40 – 9:40 am
9:40 – 10:00 am
10:00 – 11:15 am
11:15 – 11:45 pm
11:45 – 12:35 pm
12:45 – 2:00 pm
2:00 – 2:15 pm
2:15 – 3:15 pm

Welcome / Introduction
Opening Keynote, Dawn Hershman, MD, MS
Break / Exhibits / Posters
Session One
Break / Exhibits / Posters
Session Two
Closing keynote, Sue Best, LCSW


Opening Keynote Address | 8:40 – 9:40 am

Comorbidity, Toxicity, and Breast Cancer Survival
A discussion on how comorbidities increase risk during breast cancer treatment, and how non-adherence to medications impacts treatment outcomes and toxicity development.

Dawn Hershman, MD, MS
Columbia University Medical Center

Session One | 10:00 – 11:15 am

Track A

New Methods in Reconstruction
Discuss advances in breast reconstruction and review its future directions.

Hetal Fichadia, MD, FACS
The Oregon Clinic

Track B

Young Women’s Breast Cancer – What is the Role of Pregnancy?
A discussion on research focused on identifying causes of increased risk of metastasis, particularly in recently pregnant women, and investigations of breast cancer prevention through usage of non-steroidal anti-inflammatory drugs.

Pepper Schedin, PhD
OHSU Knight Cancer Institute 

Track C

Explorando las emociones que afectan al paciente y sus familias cuando enfrentan a un diagnostic de cancer

Linda Torres, LCSW
Silvia Maciel, RN
Providence Hood River Memorial Hospital

Track D

Hormone Therapy: The Basics and Beyond
Review standards of care and recently evolving antihormone treatment, as well as treatment options for HR+ metastatic breast cancer. 

Jay Andersen, MD
Compass Oncology

Track E
Metastatic Track

Exercise and Metastatic Disease: Reasons and Ways to Keep Moving
This session will discuss the reasons why exercise can be helpful for people with metastatic disease and how to make exercise both safe and effective as your cancer progresses.

Kerri Winters-Stone, PhD, FACM
Oregon Health & Science University

Session Two | 12:45 – 2:00 pm

 Track A

Genetic Testing and Surgical Implications
A discussion on enhanced genetic panels, who should get tested, and what the available screening and surgical options are for individuals with a genetic mutation.

Jennifer Garreau, MD
Gina Westhoff, MD
Legacy Health

 Track B

Racism in the Health Care System: Its Impact on the African American Patient and Their Provider
A discussion on the historical context of the African American population’s interactions with the healthcare system and the impact on well-being, and explore ways to help patients and providers mitigate the impact of racism on treatment.

Shea Lott, PhD
Avel Gordley Center for Healing, Oregon Health & Science University 

 Track C

Sexual Health and Survivorship: Effects of Breast Cancer on the Pelvic Floor
Discuss options for addressing side effects of breast cancer treatment on the pelvic floor using the most current evidence.

Megan Kaley, DPT
Providence Health and Services  

 Track D

Managing Short and Long-term Side Effects of Chemotherapy
Discuss the management of side effects associated with common chemotherapies, including peripheral neuropathy, and explore preventative health approaches for patients.

Kayla Grzybowski, PharmD, BCPS
Kirsten Kadoyama, PharmD
Kaiser Permanente

Track E
Metastatic Track

Creating Community Support Workshop – details TBD

Closing Keynote | 2:15 – 3:15 pm

Exploring Emotional and Spiritual Needs Following a Diagnosis
Discuss the range of emotions that can occur with breast cancer diagnosis and examine the meaning of spirituality vs religion, and how spiritual issues may arise.

Sue Best, LCSW
Oregon Health and Science University


Go to Top
Translate »